CHAPTER 1.Industry Overview of Intranasal Drug and Vaccine Delivery
1.1.Definition and Scope
1.1.1.Definition of Intranasal Drug and Vaccine Delivery
1.1.2.Market Segmentation
1.1.3.Years Considered for the Study
1.1.4.Assumptions and Acronyms Used
1.1.4.1.Market Assumptions and Market Forecast
1.1.4.2.Acronyms Used in Global Intranasal Drug and Vaccine Delivery Market
1.2.Summary
1.2.1.Executive Summary
1.2.2.Intranasal Drug and Vaccine Delivery Market By Product
1.2.3.Intranasal Drug and Vaccine Delivery Market By Application
1.2.4.Intranasal Drug and Vaccine Delivery Market By End Use
1.2.5.Intranasal Drug and Vaccine Delivery Market by Regions
CHAPTER 2.Research Approach
2.1.Methodology
2.1.1.Research Programs
2.1.2.Market Size Estimation
2.1.3.Market Breakdown and Data Triangulation
2.2.Data Source
2.2.1.Secondary Sources
2.2.2.Primary Sources
CHAPTER 3.Market Dynamics And Competition Analysis
3.1.Market Drivers
3.1.1.Driver 1
3.1.2.Driver 2
3.2.Restraints and Challenges
3.2.1.Restrain 1
3.2.2.Restrain 2
3.3.Growth Opportunities
3.3.1.Opportunity 1
3.3.2.Opportunity 2
3.4.Porter’s Five Forces Analysis
3.4.1.Bargaining Power of Suppliers
3.4.2.Bargaining Power of Buyers
3.4.3.Threat of Substitute
3.4.4.Threat of New Entrants
3.4.5.Degree of Competition
3.5.Market Concentration Ratio and Market Maturity Analysis of Intranasal Drug and Vaccine Delivery Market
3.5.1.Go To Market Strategy
3.5.1.1.Introduction
3.5.1.2.Growth
3.5.1.3.Maturity
3.5.1.4.Saturation
3.5.1.5.Possible Development
3.6.Technological Roadmap for Intranasal Drug and Vaccine Delivery Market
3.7.Value Chain Analysis
3.7.1.List of Key Manufacturers
3.7.2.List of Customers
3.7.3.Level of Integration
3.8.Cost Structure Analysis
3.8.1.Price Trend of Key Raw Materials
3.8.2.Raw Material Suppliers
3.8.3.Proportion of Manufacturing Cost Structure
3.8.3.1.Raw Material
3.8.3.2.Labor Cost
3.8.3.3.Manufacturing Expense
3.9.Regulatory Compliance
3.10.Competitive Landscape, 2020
3.10.1.Player Positioning Analysis
3.10.2.Key Strategies Adopted By Leading Players
CHAPTER 4.Manufacturing Plant Analysis
4.1.Manufacturing Plant Location and Establish Date of Major Manufacturers in 2020
4.2.R&D Status and Application Source of Intranasal Drug and Vaccine Delivery Major Manufacturers in 2020
CHAPTER 5.Intranasal Drug and Vaccine Delivery Market By Product
5.1.Introduction
5.2.Intranasal Drug and Vaccine Delivery Revenue By Product
5.2.1.Intranasal Drug and Vaccine Delivery Revenue (US$ Mn) and Forecast, By Product, 2017-2028
5.2.2.Liquid Delivery Device
5.2.2.1.Liquid Delivery Device Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.3.Powder Delivery Device
5.2.3.1.Powder Delivery Device Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.4.Pressurized Metered Dose Inhaler
5.2.4.1.Pressurized Metered Dose Inhaler Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.5.Others
5.2.5.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 6.Intranasal Drug and Vaccine Delivery Market Revenue By Application
6.1.Introduction
6.2.Intranasal Drug and Vaccine Delivery Revenue (US$ Mn) By Application
6.2.1.Intranasal Drug and Vaccine Delivery Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
6.2.2.Neurological Disorder
6.2.2.1.Neurological Disorder Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.3.Pain Management
6.2.3.1.Pain Management Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.4.Respiratory Disorders
6.2.4.1.Respiratory Disorders Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.5.Vaccination
6.2.5.1.Vaccination Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.6.Others
6.2.6.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 7.Intranasal Drug and Vaccine Delivery Market By End Use
7.1.Introduction
7.2.Intranasal Drug and Vaccine Delivery Revenue (US$ Mn) By End Use
7.2.1.Intranasal Drug and Vaccine Delivery Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
7.2.2.Retail Outlets
7.2.2.1.Retail Outlets Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.3.Hospital Pharmacies
7.2.3.1.Hospital Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.4.Online Platform
7.2.4.1.Online Platform Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 8.North America Intranasal Drug and Vaccine Delivery Market By Country
8.1.North America Intranasal Drug and Vaccine Delivery Overview
8.2.U.S.
8.2.1.U.S. Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
8.2.2.U.S. Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
8.2.3.U.S. Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
8.3.Canada
8.3.1.Canada Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
8.3.2.Canada Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
8.3.3.Canada Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
8.4.North America PEST Analysis
CHAPTER 9.Europe Intranasal Drug and Vaccine Delivery Market By Country
9.1.Europe Intranasal Drug and Vaccine Delivery Market Overview
9.2.U.K.
9.2.1.U.K. Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
9.2.2.U.K. Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.2.3.U.K. Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
9.3.Germany
9.3.1.Germany Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
9.3.2.Germany Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.3.3.Germany Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
9.4.France
9.4.1.France Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
9.4.2.France Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.4.3.France Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
9.5.Spain
9.5.1.Spain Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
9.5.2.Spain Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.5.3.Spain Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
9.6.Rest of Europe
9.6.1.Rest of Europe Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
9.6.2.Rest of Europe Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.6.3.Rest of Europe Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
9.7.Europe PEST Analysis
CHAPTER 10.Asia Pacific Intranasal Drug and Vaccine Delivery Market By Country
10.1.Asia Pacific Intranasal Drug and Vaccine Delivery Market Overview
10.2.China
10.2.1.China Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028
10.2.2.China Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
10.2.3.China Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
10.3.Japan
10.3.1.Japan Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028
10.3.2.Japan Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
10.3.3.Japan Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
10.4.India
10.4.1.India Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028
10.4.2.India Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
10.4.3.India Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
10.5.Australia
10.5.1.Australia Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028
10.5.2.Australia Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
10.5.3.Australia Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
10.6.South Korea
10.6.1.South Korea Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028
10.6.2.South Korea Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
10.6.3.South Korea Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
10.7.Rest of Asia-Pacific
10.7.1.Rest of Asia-Pacific Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028
10.7.2.Rest of Asia-Pacific Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
10.7.3.Rest of Asia-Pacific Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
10.8.Asia Pacific PEST Analysis
CHAPTER 11.Latin America Intranasal Drug and Vaccine Delivery Market By Country
11.1.Latin America Intranasal Drug and Vaccine Delivery Market Overview
11.2.Brazil
11.2.1.Brazil Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028
11.2.2.Brazil Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
11.2.3.Brazil Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
11.3.Mexico
11.3.1.Mexico Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028
11.3.2.Mexico Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
11.3.3.Mexico Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
11.4.Rest of Latin America
11.4.1.Rest of Latin America Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028
11.4.2.Rest of Latin America Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 – 2028
11.4.3.Rest of Latin America Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
CHAPTER 12.Middle East & Africa Intranasal Drug and Vaccine Delivery Market By Country
12.1.Middle East & Africa Intranasal Drug and Vaccine Delivery Market Overview
12.2.Saudi Arabia
12.2.1.Saudi Arabia Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028
12.2.2.Saudi Arabia Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
12.2.3.Saudi Arabia Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
12.3.UAE
12.3.1.UAE Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028
12.3.2.UAE Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
12.3.3.UAE Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
12.4.Rest of Middle East & Africa
12.4.1.Rest of Middle East & Africa Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028
12.4.2.Rest of Middle East & Africa Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
12.4.3.Rest of Middle East & Africa Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
CHAPTER 13.Player Analysis Of Intranasal Drug and Vaccine Delivery
13.1.Intranasal Drug and Vaccine Delivery Market Company Share Analysis
13.2.Competition Matrix
13.2.1.Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2.New Product Launches and Product Enhancements
13.2.3.Mergers And Acquisition In Global Intranasal Drug and Vaccine Delivery Market
13.2.4.Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14.COMPANY PROFILE
14.1.Aegis Therapeutics LLC
14.1.1.Company Snapshot
14.1.2.Business Overview
14.1.3.Financial Overview
14.1.3.1.Revenue (US$ Mn), 2020
14.1.3.2.Aegis Therapeutics LLC 2020 Intranasal Drug and Vaccine Delivery Business Regional Distribution
14.1.4.Product/ Service and Specification
14.1.5.Recent Developments & Business Strategy
14.1.6.Manufacturing Plant Footprint Analysis
14.2.AstraZeneca Plc
14.3.MedImmune, Inc.
14.4.Alza Corporation
14.5.Baxter International, Inc.
14.6.Becton, Dickinson and Company
14.7.GlaxoSmithKline Plc.
14.8.Johnson & Johnson, Inc.
14.9.Others
The Intranasal Drug and Vaccine Delivery market value is anticipated to be worth around US$ 60 Bn in 2028.
The Intranasal Drug and Vaccine Delivery market is anticipated to grow around 7.1% CAGR amid the forecast period 2021-2028.
North America held highest market share in 2019.
Asia Pacific is projected to be the fastest growing region in the global market.
The key players operating in Intranasal Drug and Vaccine Delivery market such as Aegis Therapeutics LLC, AstraZeneca Plc, MedImmune, Inc., Alza Corporation, Baxter International, Inc., Becton, Dickinson and Company, GlaxoSmithKline Plc., Johnson & Johnson, Inc., and Others.
The report provides insights on global Intranasal Drug and Vaccine Delivery market segment by product, application, end use and major geographic regions.
The Intranasal Drug and Vaccine Delivery market is segmented into North America, Europe, Asia Pacific, Latin America and The Middle East & Africa (LAMEA).
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date